BPC 157 for athletes and injury treatment: Science, safety, and legal concerns Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides Lack Reliable Safety Information, Watchdog Warns Is the lack of human data in BPC 157 a red flag? If a drug could actually knit torn tendons back together in weeks, a trillion dollar pharmaceutical industry probably wouldn't bury